Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-03 Sale |
2024-04-05 4:55 pm |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha CHIEF FINANCIAL OFFICER |
64,087 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
60,000 | $0 | 110,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2024-07-18 8:01 pm |
N/A 2034-05-01 |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
0 | $0 | 102,599 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 4:51 pm |
N/A 2034-06-14 |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
37,191 | $0 | 42,798 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha CHIEF FINANCIAL OFFICER |
1,506 | $2.59 | 64,087 (Direct) |
View |
| 2023-12-01 Tax Withholding |
2023-12-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,459 | $2.25 | 65,593 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,459 | $2.35 | 67,052 (Direct) |
View |
| 2023-06-01 Tax Withholding |
2023-06-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,459 | $4.3 | 68,511 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 6:59 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
16,595 | $0 | 17,827 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 5:56 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,721 | $5.21 | 67,378 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 8:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
1,459 | $7.75 | 69,099 (Direct) |
View |
| 2022-09-02 Option Award |
2022-09-06 7:08 pm |
N/A 2032-09-02 |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
29,482 | $0 | 29,482 (Direct) |
View |
Ownership |
2022-09-06 5:45 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
0 | $0 | 1,232 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
67,500 | $0 | 69,015 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:01 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
185,000 | $0 | 185,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 8:32 pm |
N/A 2031-06-07 |
Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |